Hirofumi Yamamoto

Title: Hirofumi Yamamoto: Innovator in Trehalose Compounds

Introduction

Hirofumi Yamamoto is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical compounds, particularly focusing on trehalose compounds. With a total of 2 patents, his work has garnered attention for its potential applications in immunology and pharmacology.

Latest Patents

Yamamoto's latest patents include innovative formulations of trehalose compounds. One of his patents describes a trehalose compound that exhibits high immunopotentiating activity and low toxicity. This compound is represented by a specific formula, where various components are defined, showcasing its potential to activate macrophages and neutrophils effectively. Another patent focuses on a trehalose compound with a high affinity for the adenosine A3 receptor, which could lead to advancements in targeted therapies.

Career Highlights

Throughout his career, Hirofumi Yamamoto has worked with prominent companies such as Glytech, Inc. and Otsuka Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in developing pharmaceutical products and innovative compounds.

Collaborations

Yamamoto has collaborated with notable colleagues, including Hiroshi Imagawa and Mugio Nishizawa. These partnerships have likely enhanced his research and development efforts in the field of trehalose compounds.

Conclusion

Hirofumi Yamamoto's contributions to the field of pharmaceutical innovations, particularly in trehalose compounds, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving therapeutic options.